Literature DB >> 18763846

Clostridium difficile: a reemerging pathogen.

David P Calfee1.   

Abstract

Clostridium difficile is an important health care-associated pathogen, especially among older adults who are disproportionately affected by C difficile infection (CDI). During the current decade, there has been a dramatic increase in the incidence and severity of health care-associated CDI. These clinically relevant changes are temporally associated with the emergence of a hypervirulent strain of C difficile that has now become widely disseminated. The increased burden of disease and incidence of adverse patient outcomes and the limitations of currently available therapeutic options highlight the importance of preventing transmission of C difficile within health care facilities, including long-term care facilities where unique challenges for infection prevention may be present. Prevention efforts should address patient-specific and facility-related risk factors. This article reviews the epidemiology, diagnosis, treatment, and prevention of C difficile infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763846

Source DB:  PubMed          Journal:  Geriatrics        ISSN: 0016-867X


  3 in total

1.  Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin.

Authors:  George Tannous; Guy Neff; Nyingi Kemmer
Journal:  Case Rep Gastroenterol       Date:  2010-09-28

2.  Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells.

Authors:  Pratik Banerjee; Glenn J Merkel; Arun K Bhunia
Journal:  Gut Pathog       Date:  2009-04-27       Impact factor: 4.181

3.  Fecal transplantation for the treatment of recurrent clostridium difficile infection.

Authors:  Zeid Karadsheh; Sachin Sule
Journal:  N Am J Med Sci       Date:  2013-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.